Multiples Private Equity has announced it has made a £6.85 billion investment with a number of other financial investors for a 9.3% stake in BDR Pharmaceuticals International Pvt. Ltd., a research and development focused integrated pharmaceutical company.
The funds will be used by the company to build additional R&D capabilities in current and emerging areas, accelerate investment in manufacturing capacity expansion, and improve the level of vertical integration. The company will also selectively pursue inorganic opportunities to build economies of scale.
Dharmesh Shah, CMD, BDR Pharma, said: “We look forward to accelerating our growth trajectory with trusted investors who have a deep understanding of the sector and regulatory environment and bring first-hand experience of working with innovative, high-growth companies .”